COSMOS Pharmaceutical Corporation

TSE:3349 Stock Report

Mkt Cap: JP¥514.8b

COSMOS Pharmaceutical Future Growth

How is COSMOS Pharmaceutical forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


7.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

TSE:3349 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
5/31/2025959,66427,3988,75451,27510
5/31/2024893,23425,2465,66748,11811
5/31/2023825,19623,6911,53445,71011
11/30/2022788,29223,209-3,65541,973N/A
8/31/2022772,12723,393N/AN/AN/A
5/31/2022755,41423,155-11,30332,194N/A
2/28/2022743,61222,030N/AN/AN/A
11/30/2021733,38725,329-535,596N/A
8/31/2021726,67225,909N/AN/AN/A
5/31/2021726,42427,1561,81127,875N/A
2/28/2021733,22328,777N/AN/AN/A
11/30/2020723,30925,73628,88250,935N/A
8/31/2020709,06423,876N/AN/AN/A
5/31/2020684,40321,43539,51365,461N/A
2/29/2020653,52720,217N/AN/AN/A
11/30/2019638,03418,95110,65338,209N/A
8/31/2019622,10319,349N/AN/AN/A
5/31/2019611,13719,1855,33934,379N/A
2/28/2019597,71518,966N/AN/AN/A
11/30/2018585,53618,8571,30230,947N/A
8/31/2018572,80717,880N/AN/AN/A
5/31/2018557,99917,6333,13532,586N/A
2/28/2018542,93617,510N/AN/AN/A
11/30/2017526,52317,3136,81435,488N/A
8/31/2017514,88018,239N/AN/AN/A
5/31/2017502,73218,2158,27136,938N/A
2/28/2017490,03715,812N/AN/AN/A
11/30/2016477,73914,9815,95534,300N/A
8/31/2016463,51713,679N/AN/AN/A
5/31/2016447,27312,435N/A30,986N/A
2/29/2016433,32812,738N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 3349's forecast earnings growth (7.2% per year) is above the savings rate (0.04%).

Earnings vs Market: 3349's earnings (7.2% per year) are forecast to grow slower than the JP market (8.3% per year).

High Growth Earnings: 3349's earnings are forecast to grow, but not significantly.

Revenue vs Market: 3349's revenue (7.5% per year) is forecast to grow faster than the JP market (4.1% per year).

High Growth Revenue: 3349's revenue (7.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 3349's Return on Equity is forecast to be low in 3 years time (11.3%).


Discover growth companies